pharmaceutical investing Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
pharmaceutical investing VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study
pharmaceutical investing Melinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE
pharmaceutical investing Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients
SAGA Metals Highlights Radar Project's VTM Enriched Magnetic Concentrate up to 0.9% V2O5 Relative to Panzhihua, China Benchmark of 0.3% V2O5
